[Surface markers and prognostic relevance of non-Hodgkin's lymphoma--clinical studies of lymphoma patients at the Shikoku Cancer Center Hospital].
We report data on the relationship between surface markers and prognosis in non-Hodgkin's lymphoma treated at Shikoku Cancer Center Hospital. Between 1979 and 1982 we encountered 47 non-Hodgkin's lymphoma patients and 6 patients with Hodgkin's disease. Of 27 lymphoma cases studied, surface marker studies revealed 12 (44%) to be of T-cell type, 13 (48%) of B-cell type and 2 (7%) of Null-cell type. Patients with T-cell type lymphoma manifested a poor prognosis compared to those with B-cell type. Four patients treated by chemotherapy experienced complete remission and survived by more than 3 years without relapse; they may be considered cured.
D000911:Antibodies, Monoclonal / Q000276:immunology; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis*; D011379:Prognosis; D011947:Receptors, Antigen, B-Cell / Q000032:analysis
D000911:Antibodies, Monoclonal; D011947:Receptors, Antigen, B-Cell